Drug labels often lack infant-specific information, despite U.S. government legislation encouraging drug studies involving children, a new study finds. The research focused on neonates, who are infants up to 28 days of age. They are at ...
Tags: drug labels, infant-specific information, drug studies, neonates
The U.S. Food and Drug Administration warns doctors of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test agents. The cardiac nuclear stress test agents Lexiscan, or regadenoson, and Adenoscan, ...
Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all health care practitioners and Canadians. Canada health ...
Tags: Drug Safety, Labeling Initiative
Health Canada has announced the labeling update for all cholesterol-lowering drugs (statins). The update warns about the risk of increased blood sugar levels and an increased risk of diabetes among patients with pre-existing risk factors ...
Health Canada will inform Canadians of a labeling update for all cholesterol-lowering drugs, which are also known as statins, regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients who are ...
Tags: drug labels, Healthcare, statins
A study by US-based researchers, published in the journal PLoS, found that these warning labels often carry information about drug interactions or dosage information. The study found that consumers, particularly older ones, often overlook ...
Tags: Drug Warning Labels, Label, packaging, warning labels
Amplion Research has launched BiomarkerBase, the first available database of every biomarker currently in active clinical use. BiomarkerBase is an easy to use data container and provides quick access to the detailed information available ...
Tags: Amplion, BiomarkerBase, clinical use, data container